Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor

Surgery (United States)

Volumn 152, Issue 5, 2012, Pages 879-885

  Duru, Enrico A ^a   Fu, Yuyang ^a   Davies, Mark G ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; APOCYNIN; DIPHENYLIODONIUM SALT; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; OXYGEN RADICAL; PROTEIN TYROSINE KINASE; RAC PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SMALL INTERFERING RNA; UROKINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

CELL MOVEMENT; CELLS, CULTURED; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84867582126     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.03.004     Document Type: Article

References (31)

1. F. Blasi, and P. Carmeliet uPAR: a versatile signaling orchestrator Nat Cell Biol 3 2002 932 943
2. B.H. Strauss, H.K. Lau, K.A. Bowman, J. Sparkes, R.J. Chisholm, and M.B. Garvey Plasma urokinase antigen and PAI-1 antigen levels predict angiographic coronary restenosis Circulation 100 1999 1616 1622
3. W.J. Tanski, A.J. Fegley, E. Roztocil, and M.G. Davies Domain dependent actions of urokinase on smooth muscle cell responses J Vasc Surg 39 2004 214 222
4. Galaria II, S.M. Nicholl, E. Roztocil, and M.G. Davies Urokinase-induced smooth muscle cell migration requires both PI3-K / akt and PI3-K / ERK1/2 activation J Surg Res 127 2005 46 52
5. A.M. Bakken, C.D. Protack, E. Roztocil, S.M. Nicholl, and M.G. Davies Cell migration in response to the amintoterminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism J Vasc Surg 49 2009 1296 1303
6. S.M. Nicholl, E. Roztocil, and M.G. Davies Urokinase (uPA) induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor J Vasc Surg 41 2005 672 681
7. W.J. Tanski, S.M. Nicholl, D. Kim, A.J. Fegley, E. Roztocil, and M.G. Davies Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin J Vasc Surg 39 2005 91 98
8. E. Roztocil, S.M. Nicholl, and M.G. Davies S-1-P induced VSMC migration via activation of NAD(P)H oxidase requires Gα12/13 protein mediated phospholipase C activation J Vasc Surg 46 2007 1253 1259
9. R. Wetzker, and F.D. Bohmer Transactivation joins multiple tracks to the ERK/MAPK cascade Nat Rev Mol Cell Biol 4 2003 651 657
10. K.L. Pierce, A. Tohgo, S. Ahn, M.E. Field, L.M. Luttrell, and R.J. Lefkowitz Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding J Biol Chem 276 2001 23155 23160
11. N. Prenzel, E. Zwick, H. Daub, M. Leserer, R. Abraham, and C. Wallasch EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 1999 884 888
12. M. Suzuki, G. Raab, M.A. Moses, C.A. Fernandez, and M. Klagsbrun Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site J Biol Chem 272 1997 31730 31737
13. C. Patterson, J. Ruef, N.R. Madamanchi, P. Barry-Lane, Z. Hu, and C. Horaist Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo J Biol Chem 274 1999 19814 19822
14. W.T. Gerthoffer Mechanisms of vascular smooth muscle cell migration Circ Res 100 2007 607 621
15. H. Cai, K.K. Griendling, and D.G. Harrison The vascular NAD(P)H oxidase as therapeutic targets in cardiovascular diseases TIPS 24 2003 471 478
16. L. Van Heerebeek, C. Meischi, W. Stooker, C.J. Meijer, H.W. Niessen, and D. Roos NADPH oxidase(s): new sources of reactive oxygen species in the vascular system? J Clin Pathol 55 2002 561 568
17. R.M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, and M.T. Quinn Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II Circ Res 90 2002 1205 1213
18. M.C. Lavigne, H.L. Malech, S.M. Holland, and T.L. Leto Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells Circulation 104 2001 79 84
19. B. Schieffer, M. Luchtefeld, S. Braun, A. Hilfiker, D. Hilfiker-Kleiner, and H. Drexler Role of NAD(P)H oxidase in angiotensin II-induced JAK-stat singaling and cytokine production Circ Res 87 2000 1195 1202
20. B.M. Babior, J.D. Lambeth, and W. Nauseef The neutrophil NADPH oxidase Arch Biochem Biophys 397 2002 342 344
21. A. Manea NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology Cell Tissue Res 342 2010 325 339
22. P.L. Hordijk Regulation of NADPH oxidases: the role of Rac proteins Circ Res 98 2006 453 462
23. M. Terashima, Y. Ohashi, H. Azumi, K. Otsui, H. Kaneda, and K. Awano Impact of NAD(P)H oxidase-derived reactive oxygen species on coronary arterial remodeling: a comparative intravascular ultrasound and histochemical analysis of atherosclerotic lesions Circ Cardiovasc Interv 2 2009 196 204
24. Y. Shi, R. Niculescu, D. Wang, S. Patel, K.L. Davenpeck, and A. Zalewski Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury Arterioscler Thromb Vasc Biol 21 2001 739 745
25. M. Lee, A. San Martin, P.K. Mehta, A.E. Dikalova, A.M. Garrido, and S.R. Datla Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation Arterioscler Thromb Vasc Biol 29 2009 480 487
26. H.M. Dourron, G.M. Jacobson, J.L. Park, J. Liu, D.J. Reddy, and M.L. Scheel Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery Am J Physiol Heart Circ Physiol 288 2005 H946 H953
27. G.M. Jacobson, H.M. Dourron, J. Liu, O.A. Carretero, D.J. Reddy, and T. Andrzejewski Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery Circ Res 92 2003 637 643
28. O.S. Plekhanova, M.Y. Men'shikov, P.P. Bashtrykov, B.C. Berk, V.A. Tkachuk, and E.V. Parfenova Urokinase induces ROS production in vascular smooth muscle cells Bull Exp Biol Med 142 2006 304 307
29. M. Menshikov, O. Plekhanova, H. Cai, K. Chalupsky, Y. Parfyonova, and P. Bashtrikov Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways Arterioscler Thromb Vasc Biol 26 2006 801 807
30. A. Kalmes, B.R. Vesti, G. Daum, J.A. Abraham, and A.W. Clowes Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor Circ Res 87 2000 92 98
31. M. Shinohara, Y. Adachi, J. Mitsushita, M. Kuwabara, A. Nagasawa, and S. Harada Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration J Biol Chem 285 2010 4481 4488